Does fetal fibronectin testing change patient management in women at risk of preterm labour?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 146, Issue 2, 2009, Pages 180-183

  Bolt, Lauren A ^a   Chandiramani, Manju ^a   De Greeff, Annemarie ^a   Seed, Paul ^a   Shennan, Andrew H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Fetal fibronectin; Management; Prediction; Spontaneous preterm birth

Indexed keywords

FIBRONECTIN;

ADULT; ARTICLE; FEMALE; FETAL FIBRONECTIN TEST; FETUS; FOLLOW UP; FUNCTION TEST; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK FACTOR;

EID: 70349515307     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.06.021     Document Type: Article

References (14)

1. Slattery M., and Morrison J. Preterm delivery. Lancet 9344 (2002) 1489-1497
2. Larroque B., Ancel P.-Y., Marret S., et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 371 (2008) 813-820
3. Creasy R.K., Gummer B.A., and Liggins G.C. System for predicting spontaneous preterm birth. Obstet Gynecol 55 (1980) 692-695
4. Goldenberg R.L., Goepfert A.R., and Ramsey P.S. Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol 192 (2005) S36-46
5. Goldenberg R.L., Iams J.D., Mercer B.F.M., et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health 88 (1998) 233-238
6. Goldenberg R.L., Culhane J.F., Iams J.D., and Romero R. Epidemiology and causes of preterm birth. Lancet 371 (2008) 75-84
7. Peaceman A.M., Andrews W.W., Thorp J.M., et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 177 1 (1997) 13-18
8. Abenhaim H., Morin L., and Benjamin A. Does availability of fetal fibronectin testing in the management of threatened preterm labour affect the utilization of hospital resources?. Can J Obstet Gynaecol 27 (2005) 689-694
9. Tanir H.M., Sener T., and Yildiz Z. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study. Clin Exp Obstet Gynecol 35 (2008) 61-64
10. Lockwood C.J., Senyei A.E., Dische M.R., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 325 (1991) 669-674
11. Smith V., Devane D., Begley C., Clarke M., and Higgins S. A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol 133 (2007) 134-142
12. Joffe G.M., Jacques D., Bemis-Heys R., Burton R., Skram B., and Shelburne P. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 180 (1999) 581-586
13. Berghella V., Hayes E., Visintine J., and Baxter J.K. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev Issue 4 (2008) Art. No:CD006843
14. Grobman W.A., Welshman E.E., and Calhoun E.A. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behaviour and health care costs? A randomized trial. Am J Obstet Gynecol 191 (2004) 235-240